To confirm the effect of IGF2BP3 on chemotherapy sensitivity of bladder cancer, CCK-8 and flow cytometry were used to detect the effect of IGF2BP3 on cisplatin sensitivity of bladder cancer cells. This evidence concerns the gene IGF2BP3 and urinary bladder cancer.